Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Harvard Apparatus Regenerative Technology, Inc. | Director | Stock Option (right to buy) | 8.22K | Jun 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HRGN | Harvard Apparatus Regenerative Technology, Inc. | Jun 27, 2024 | 2 | $0 | 4 | Jul 15, 2024 | Director |
BSTG | Harvard Apparatus Regenerative Technology, Inc. | Jul 26, 2023 | 2 | $0 | 4 | Jul 28, 2023 | Director |
BSTG | Biostage, Inc. | Feb 28, 2023 | 3 | $0 | 4 | Mar 2, 2023 | CEO as of 2/28/2023, Director |
BSTG | Biostage, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | CEO, Director |
BSTG | Biostage, Inc. | May 12, 2022 | 2 | $375K | 4 | May 23, 2022 | Interim CEO, Director |
BSTG | Biostage, Inc. | Nov 26, 2021 | 3 | $250K | 4 | Nov 30, 2021 | Interim CEO, Director |
BSTG | Biostage, Inc. | Nov 26, 2021 | 0 | $0 | 3 | Nov 30, 2021 | Interim Chief Executive Officer, Director |